Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-011331
Filing Date
2013-02-21
Accepted
2013-02-21 16:05:45
Documents
1
Period of Report
2013-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd370665.html 4  
1 FORM 4 rrd370665.xml 4 3145
  Complete submission text file 0001181431-13-011331.txt   4699
Mailing Address 1 GRAND CANAL SQUARE DOCKLANDS, DUBLIN 2, IRELAND L2 00000
Business Address 1 GRAND CANAL SQUARE DOCKLANDS, DUBLIN 2, IRELAND L2 00000 353 1 897 2000
Warner Chilcott plc (Issuer) CIK: 0001323854 (see all company filings)

EIN.: 980626948 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866
Business Address
Halstead Michael (Reporting) CIK: 0001521548 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53772 | Film No.: 13630447